Home LiteratureArticle Details
PMID: 11228544 Published · ppublish English Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients.

Neoplasia (New York, N.Y.) ·Vol. 2 ·No. 6 ·2000-00-00 ·Pages 514-22

Thorstensen L, Qvist H, Heim S, Liefers GJ, Nesland JM, Giercksky KE, Lothe RA

Abstract

Cytogenetic and molecular genetic analyses of colorectal adenomas and carcinomas have shown that loss of the distal part of chromosome arm 1p is common, particularly in tumors of the left colon. Because the importance of 1p loss in colorectal cancer metastases is unknown, we compared the frequency, exact site and extent of 1p deletions in primary carcinomas (n=28), local recurrences (n=19) and metastases (n=33) from 67 colorectal cancer patients using 14 markers in an allelic imbalance study. Loss of 1p was found in 50% of the primary carcinomas, 33% of the local recurrences, and 64% of the metastases, revealing a significant difference between the local recurrences and the metastases (P=.04). The smallest region of 1p deletion overlap (SRO) defined separately for each group of lesions had the region between markers D1S2647 and D1S2644, at 1p35-36, in common. The genes PLA2G2A (1p35.1-36) and TP73 (1p36.3) were shown to lie outside this consistently lost region, suggesting that neither of them are targets for the 1p loss. In the second part of the study, microdissected primary carcinomas and distant metastases from the same colorectal cancer patients (n=18) were analyzed, and the same 1p genotype was found in the majority of patients (12/18, 67%). The finding that primary carcinoma cells with metastatic ability usually contain 1p deletions, and that some cases lacking 1p alterations in the primary tumor acquire such changes during growth of a metastatic lesion, supports the notion that 1p loss may be important both early and late in colorectal carcinogenesis, with the apparent exception of local recurrences.

MeSH Terms
Adenocarcinoma/genetics,secondary Adolescent Adult Aged Aged, 80 and over Chromosome Deletion Chromosomes, Human, Pair 1/genetics Colorectal Neoplasms/genetics,pathology DNA, Neoplasm/isolation & purification Female Humans Liver Neoplasms/genetics,secondary Loss of Heterozygosity Lung Neoplasms/genetics,secondary Male Microsatellite Repeats Middle Aged Neoplasm Recurrence, Local/genetics,pathology Peritoneal Neoplasms/genetics,secondary Polymerase Chain Reaction Polymorphism, Restriction Fragment Length
Chemicals
DNA, Neoplasm
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Thorstensen L
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway.
Qvist H
Heim S
Liefers G J
Nesland J M
Giercksky K E
Lothe R A
References (44)
44 references, click to expand
  1. Allelotype of colorectal carcinomas.
    Science. 1989 Apr 14;244(4901):207-11 PMID: 2565047
  2. Cytogenetics of colorectal adenocarcinomas.
    Cancer Genet Cytogenet. 1990 Jun;46(2):143-56 PMID: 2340486
  3. Human colorectal cancer: high frequency of deletions at chromosome 1p35.
    Cancer Res. 1990 Nov 15;50(22):7232-5 PMID: 1977517
  4. Karyotype peculiarities of human colorectal adenocarcinomas.
    Hum Genet. 1991 Mar;86(5):491-6 PMID: 2016090
  5. Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis.
    Br J Cancer. 1991 Sep;64(3):475-80 PMID: 1911187
  6. Loss of heterozygosity at the human RAP1A/Krev-1 locus is a rare event in colorectal tumors.
    Cancer Res. 1992 Jan 15;52(2):285-9 PMID: 1345809
  7. Chromosome 1 in human colorectal tumors. Cytogenetic research on structural changes and their significance.
    Hum Genet. 1992 Feb;88(4):431-8 PMID: 1740320
  8. Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinicopathologic features.
    Cancer. 1993 Jan 15;71(2):306-14 PMID: 8422622
  9. Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma.
    Int J Cancer. 1993 Feb 1;53(3):382-7 PMID: 8094072
  10. Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis.
    Cancer Res. 1993 Apr 15;53(8):1895-8 PMID: 8467511
  11. Suppression of tumourigenicity in human colon carcinoma cells by introduction of normal chromosome 1p36 region.
    Oncogene. 1993 Aug;8(8):2253-8 PMID: 8101648
  12. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse.
    Cell. 1993 Nov 19;75(4):631-9 PMID: 8242739
  13. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
    Oncogene. 1994 Apr;9(4):1053-6 PMID: 7907781
  14. Karyotypic characterization of colorectal adenocarcinomas.
    Genes Chromosomes Cancer. 1995 Feb;12(2):97-109 PMID: 7535093
  15. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
    Anticancer Res. 1995 Jan-Feb;15(1):13-24 PMID: 7733622
  16. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.
    Cell. 1995 Jun 16;81(6):957-66 PMID: 7781071
  17. Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer.
    Oncogene. 1995 Oct 5;11(7):1357-62 PMID: 7478557
  18. Absence of secretory phospholipase A2 gene alterations in human colorectal cancer.
    Cancer Res. 1995 Nov 15;55(22):5184-6 PMID: 7585570
  19. Human homologue of a candidate for the Mom1 locus, the secretory type II phospholipase A2 (PLA2S-II), maps to 1p35-36.1/D1S199.
    Cancer Res. 1995 Dec 1;55(23):5504-6 PMID: 7585622
  20. Deletion of 1p loci and microsatellite instability in colorectal polyps.
    Genes Chromosomes Cancer. 1995 Nov;14(3):182-8 PMID: 8589034
  21. A comprehensive genetic map of the human genome based on 5,264 microsatellites.
    Nature. 1996 Mar 14;380(6570):152-4 PMID: 8600387
  22. Chromosome abnormalities in colorectal adenomas: two cytogenetic subgroups characterized by deletion of 1p and numerical aberrations.
    Hum Pathol. 1996 Nov;27(11):1192-7 PMID: 8912830
  23. Microsatellite instability in human solid tumors.
    Mol Med Today. 1997 Feb;3(2):61-8 PMID: 9060003
  24. Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP.
    Hum Genet. 1997 Sep;100(3-4):345-9 PMID: 9272153
  25. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.
    Cell. 1997 Aug 22;90(4):809-19 PMID: 9288759
  26. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis.
    Nat Genet. 1997 Sep;17(1):88-91 PMID: 9288104
  27. p73 is a simian [correction of human] p53-related protein that can induce apoptosis.
    Nature. 1997 Sep 11;389(6647):191-4 PMID: 9296498
  28. Allelic imbalance and cytogenetic deletion of 1p in colorectal adenomas: a target region identified between DIS199 and DIS234.
    Genes Chromosomes Cancer. 1998 Mar;21(3):185-94 PMID: 9523193
  29. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers.
    Cancer Res. 1998 Apr 1;58(7):1380-3 PMID: 9537234
  30. Comparison of genetic changes in frozen biopsies and microdissected archival material from the same colorectal liver metastases.
    Diagn Mol Pathol. 1997 Dec;6(6):318-25 PMID: 9559291
  31. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma.
    Cancer Res. 1998 May 15;58(10):2076-7 PMID: 9605745
  32. Activation of p73 silent allele in lung cancer.
    Cancer Res. 1998 Jun 1;58(11):2347-9 PMID: 9622072
  33. Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas.
    Int J Oncol. 1998 Aug;13(2):319-23 PMID: 9664127
  34. Intratumor distribution of 1p deletions in human colorectal adenocarcinoma is commonly homogeneous: indirect evidence of early involvement in colorectal tumorigenesis.
    Cancer. 1998 Aug 1;83(3):415-22 PMID: 9690532
  35. Cytogenetic analysis of colorectal adenomas: karyotypic comparisons of synchronous tumors.
    Cancer Genet Cytogenet. 1998 Oct 1;106(1):66-71 PMID: 9772912
  36. Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa.
    Oncogene. 1998 Oct 15;17(15):2009-12 PMID: 9788445
  37. Loss of imprinting and allele switching of p73 in renal cell carcinoma.
    Oncogene. 1998 Oct 1;17(13):1739-41 PMID: 9796703
  38. p73, a gene related to p53, is not mutated in esophageal carcinomas.
    Int J Cancer. 1998 Nov 9;78(4):437-40 PMID: 9797131
  39. Cloning of the human aflatoxin B1-aldehyde reductase gene at 1p35-1p36.1 in a region frequently altered in human tumor cells.
    Cancer Res. 1998 Nov 15;58(22):5014-8 PMID: 9823300
  40. Detailed deletion mapping on chromosome 1p32-p36 in human colorectal cancer: identification of three distinct regions of common allelic loss.
    Int J Oncol. 1998 Dec;13(6):1229-33 PMID: 9824636
  41. Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines.
    Cell Growth Differ. 1998 Nov;9(11):897-903 PMID: 9831242
  42. Refined chromosomal localization of the putative tumor suppressor gene TP73.
    Cytogenet Cell Genet. 1998;82(3-4):199-201 PMID: 9858816
  43. Mutational and expression analysis of the p73 gene in melanoma cell lines.
    Cancer Res. 1999 Jan 1;59(1):172-4 PMID: 9892203
  44. Mutational analysis of p73 and p53 in human cancer cell lines.
    Oncogene. 1999 Jun 3;18(22):3415-21 PMID: 10362363
Article Info
Journal
Neoplasia (New York, N.Y.)
Abbr.
Neoplasia
ISSN
1522-8002
Published
2000-00-00
Pages
514-22
Language
English
Region
United States
NLM ID
100886622
PMCID
PMC1508083
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com